Factors Influencing the Prevalence of Resistance-Associated Substitutions in NS5A Protein in Treatment-Naive Patients with Chronic Hepatitis C

Direct-acting antivirals (DAAs) revolutionized treatment of hepatitis C virus (HCV) infection. Resistance-associated substitutions (RASs) present at the baseline impair response to DAA due to rapid selection of resistant HCV strains. NS5A is indispensable target of the current DAA treatment regimens...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyuregyan, Karen K., Kichatova, Vera S., Karlsen, Anastasiya A., Isaeva, Olga V., Solonin, Sergei A., Petkov, Stefan, Nielsen, Morten, Isaguliants, Maria G., Mikhailov, Mikhail I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235841/
https://www.ncbi.nlm.nih.gov/pubmed/32272736
http://dx.doi.org/10.3390/biomedicines8040080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235841/
https://www.ncbi.nlm.nih.gov/pubmed/32272736
http://dx.doi.org/10.3390/biomedicines8040080

Ejemplares similares